Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
6
×
biotech
national top stories
boston blog main
boston top stories
fda
san francisco top stories
clinical trials
europe top stories
gene therapy
genentech
indiana blog main
indiana top stories
national
new york top stories
novartis
roche
san francisco blog main
boston
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
europe blog main
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute lymphoblastic leukemia
aimmune therapeutics
What
fda
6
×
therapy
6
×
drug
approval
gene
approved
friday
medicine
new
oral
patients
roche
therapeutics
won
address
agency
aimmune
allergy
approves
aren’t
atrophy
awarded
betting
billion
bio
biopharma
blueprint
cancer
carries
certain
chemistry
cmc
consistent
controls
daily
deal
designed
developed
developers
drugs
Language
unset
Current search:
" national blog main "
×
fda
×
therapy
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More